Exagen, Inc. (XGN)
7.65
-0.27
(-3.41%)
USD |
NASDAQ |
Aug 24, 16:00
7.61
-0.04
(-0.52%)
After-Hours: 20:00
Exagen Total Assets (Quarterly) : 51.94M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.94M |
| March 31, 2026 | 51.96M |
| December 31, 2025 | 59.20M |
| September 30, 2025 | 62.82M |
| June 30, 2025 | 58.76M |
| March 31, 2025 | 40.29M |
| December 31, 2024 | 45.40M |
| September 30, 2024 | 43.60M |
| June 30, 2024 | 49.31M |
| March 31, 2024 | 50.81M |
| December 31, 2023 | 56.94M |
| September 30, 2023 | 60.93M |
| June 30, 2023 | 64.18M |
| March 31, 2023 | 79.23M |
| December 31, 2022 | 87.63M |
| September 30, 2022 | 101.60M |
| June 30, 2022 | 106.85M |
| March 31, 2022 | 122.04M |
| December 31, 2021 | 124.17M |
| September 30, 2021 | 127.77M |
| June 30, 2021 | 133.32M |
| March 31, 2021 | 137.52M |
| December 31, 2020 | 79.01M |
| September 30, 2020 | 79.99M |
| June 30, 2020 | 80.51M |
| Date | Value |
|---|---|
| March 31, 2020 | 84.64M |
| December 31, 2019 | 88.31M |
| September 30, 2019 | 92.74M |
| June 30, 2019 | 33.09M |
| March 31, 2019 | 31.15M |
| December 31, 2018 | 29.31M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 14.63M |
| September 30, 2015 | 15.79M |
| June 30, 2015 | 15.85M |
| March 31, 2015 | 16.15M |
| December 31, 2014 | 17.15M |
| September 30, 2014 | 16.95M |
| June 30, 2014 | 15.29M |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 638.90M |
| BioRestorative Therapies, Inc. | 4.640M |
| CareDx, Inc. | 532.99M |
| Natera, Inc. | 2.657B |
| Sera Prognostics, Inc. | 86.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.72M |
| Shareholders Equity (Quarterly) | 12.22M |
| Debt to Equity Ratio | 2.264 |
| Current Ratio | 3.185 |
| Net Debt Paydown Yield | -0.75% |